Hypercoagulation detected by routine and global laboratory hemostasis assays in patients with infective endocarditis

Ekaterina M Koltsova1,2, Maria A Sorokina1, Alexandra S Pisaryuk3,4

  • 1Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.

Plos One
|December 15, 2021
PubMed

Insights

Infective endocarditis (IE) involves hypercoagulability and platelet activation. Some patients show hypocoagulation, possibly indicating consumption coagulopathy, but genetic factors did not link to embolism or mortality in this IE study.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Infectious Diseases

Background:

  • The coagulation system plays a critical role in infective endocarditis (IE) vegetation development and embolization.
  • Understanding coagulation and platelet status in IE is crucial for managing complications.

Purpose of the Study:

  • To assess coagulation and platelet status in IE patients using diverse laboratory assays.
  • To investigate the role of prothrombotic genetic polymorphisms in IE-related embolization and mortality.

Main Methods:

  • 37 IE patients were studied, assessing coagulation via standard assays (APTT, prothrombin, fibrinogen, D-dimer) and integral assays (TEG, TD).
  • Platelet functional activity was evaluated using flow cytometry.
  • Genetic polymorphisms in coagulation system genes were analyzed.

Main Results:

  • Elevated fibrinogen and fibrinogen-dependent TEG/TD parameters indicated systemic inflammation in IE patients.
  • Most patients exhibited hypercoagulation, evidenced by clot growth rate and D-dimer levels.
  • Some patients presented with hypocoagulation (prothrombin, TEG, TD), and resting platelets showed activation; decreased fibrinogen/TD correlated with fatal outcomes, while decreased TEG R parameter indicated embolism. No genetic associations were found.

Conclusions:

  • IE is generally characterized by hypercoagulability and platelet pre-activation.
  • A subset of IE patients may develop a hypocoagulant profile, potentially signifying consumption coagulopathy.
  • Genetic polymorphisms were not associated with embolism or mortality in this IE cohort.
Abstract

Related Concept Videos

Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
43
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
74
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
54
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
38
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.0K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
112